ID   FHJQ-01
AC   CVCL_A7RN
DR   IHW; IHW09504
DR   Wikidata; Q107115001
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*24:02:01:02L,01:01:01:01; B*37:01:01,08:01:01:01; C*01:02:01,07:01:01:01; DPA1*01:03:01:02,02:01:02; DPB1*04:01:01:01,01:01:01; DQA1*03:03:01:01,05:01:01:02; DQB1*03:01:01:01,02:01:01; DRB1*04:07:01,03:01:01; DRB3*01:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//